A Manchester Royal Infirmary doctor and researcher has coordinated a national team of experts to publish guidance for clinicians to help them safely manage hyperlipidaemia patients during the pandemic
In January, Sindhu John was named as one of the highly commended members of Research and Innovation staff for 2020: Year of the Nurse and Midwife. She reflects on her year in this blog.
In January, Womba Mubita was named as one of the highly commended members of Research and Innovation staff for 2020: Year of the Nurse and Midwife. She reflects on her year in this blog.
In January, Vicki Conroy was named as the MFT YNM2020 Nurse of the Year for Research and Innovation. She shares her pride in both the award and her team, and reflects on her experiences, in this blog
A 3D-printed medical device made in Manchester could help improve surgical outcomes for patients with abdominal aortic aneurysm (AAA) – a potentially life-threatening condition in the body’s main bloo
Cellular (T-cell) immunity against SARS-CoV-2 is likely to be present within most adults for at least six months after infection, according to research carried out at MFT.
The first UK patient has been treated in new COVID-19 research trialling the impact of an experimental arthritis drug, otilimab, on severe lung disease related to COVID-19.
A Wythenshawe Hospital patient with COVID-19 is the first Manchester University NHS Foundation Trust recruit to a clinical trial investigating the drug Anakinra to treat COVID-19.